398 related articles for article (PubMed ID: 17592509)
1. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
[TBL] [Abstract][Full Text] [Related]
2. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
[TBL] [Abstract][Full Text] [Related]
3. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
Wang X; Horswill JG; Whalley BJ; Stephens GJ
Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
[TBL] [Abstract][Full Text] [Related]
4. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
5. Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.
Nguyen T; German N; Decker AM; Langston TL; Gamage TF; Farquhar CE; Li JX; Wiley JL; Thomas BF; Zhang Y
J Med Chem; 2017 Sep; 60(17):7410-7424. PubMed ID: 28792219
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulators restore orthosteric agonist binding to mutated CB
Dopart R; Kendall DA
J Pharm Pharmacol; 2020 Jan; 72(1):84-91. PubMed ID: 31722122
[TBL] [Abstract][Full Text] [Related]
7. Diarylureas Containing 5-Membered Heterocycles as CB
Nguyen T; Gamage TF; Decker AM; German N; Langston TL; Farquhar CE; Kenakin TP; Wiley JL; Thomas BF; Zhang Y
ACS Chem Neurosci; 2019 Jan; 10(1):518-527. PubMed ID: 30188693
[TBL] [Abstract][Full Text] [Related]
8. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
10. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
[TBL] [Abstract][Full Text] [Related]
11. Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).
Kulkarni PM; Kulkarni AR; Korde A; Tichkule RB; Laprairie RB; Denovan-Wright EM; Zhou H; Janero DR; Zvonok N; Makriyannis A; Cascio MG; Pertwee RG; Thakur GA
J Med Chem; 2016 Jan; 59(1):44-60. PubMed ID: 26529344
[TBL] [Abstract][Full Text] [Related]
12. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).
German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y
J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172
[TBL] [Abstract][Full Text] [Related]
13. Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.
Laprairie RB; Kulkarni AR; Kulkarni PM; Hurst DP; Lynch D; Reggio PH; Janero DR; Pertwee RG; Stevenson LA; Kelly ME; Denovan-Wright EM; Thakur GA
ACS Chem Neurosci; 2016 Jun; 7(6):776-98. PubMed ID: 27046127
[TBL] [Abstract][Full Text] [Related]
14. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.
McLaughlin PJ; Qian L; Wood JT; Wisniecki A; Winston KM; Swezey LA; Ishiwari K; Betz AJ; Pandarinathan L; Xu W; Makriyannis A; Salamone JD
Pharmacol Biochem Behav; 2006 Mar; 83(3):396-402. PubMed ID: 16616951
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.
Basavarajappa BS; Hungund BL
Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126
[TBL] [Abstract][Full Text] [Related]
16. PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor.
Meini S; Gado F; Stevenson LA; Digiacomo M; Saba A; Codini S; Macchia M; Pertwee RG; Bertini S; Manera C
Eur J Med Chem; 2020 Oct; 203():112606. PubMed ID: 32682199
[TBL] [Abstract][Full Text] [Related]
17. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.
Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA
Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940
[TBL] [Abstract][Full Text] [Related]
18. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
[TBL] [Abstract][Full Text] [Related]
19. The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect.
Buechler HM; Sumi M; Madhuranthakam IM; Donegan C; DiGiorgio F; Acosta AA; Uribe S; Rahman MA; Sorbello A; Fischer BD; Keck TM
Pharmacol Biochem Behav; 2024 Jul; 240():173776. PubMed ID: 38679080
[TBL] [Abstract][Full Text] [Related]
20. A neutral CB1 receptor antagonist reduces weight gain in rat.
Chambers AP; Vemuri VK; Peng Y; Wood JT; Olszewska T; Pittman QJ; Makriyannis A; Sharkey KA
Am J Physiol Regul Integr Comp Physiol; 2007 Dec; 293(6):R2185-93. PubMed ID: 17959701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
